Search Results 731-740 of 13511 for Incidence

  1. Neostigmine (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Blurred or loss of vision; changes in patterns and rhythms of speech; chest pain or discomfort; confusion; cough; difficult or labored ...

  2. Plasma (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position; fast heartbeat; hives, itching, or ...

  3. Publications - Catherine W. Njathi-Ori, M.D. - Mayo Clinic

    Perioperative Ulnar Neuropathy: A Contemporary Estimate of Incidence and Risk Factors. Anesth Analg. 2021 May 1; 132 (5):1429-1437. View PubMed; Pepper MB ...

  4. Albumin human (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Blurred vision; chest discomfort; chills; confusion; dizziness, faintness, or lightheadedness when getting up suddenly from a lying or ...

  5. Caffeine and sodium benzoate (injection route) - Mayo Clinic

    Incidence not known. Anxiety; continuing ringing or buzzing or other unexplained noise in the ears; headache; hearing loss; hyperventilation; increased ...

  6. Lincomycin (injection route) - Side effects & uses - Mayo Clinic

    Incidence not known. Abdominal or stomach pain or tenderness; black, tarry stools; blistering, peeling, or loosening of the skin; blurred vision; chills; clay ...

  7. Bempedoic acid and ezetimibe (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known ... Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

  8. Lumbar Puncture Clinical Trials - Mayo Clinic Research

    A Study of the Incidence of Post Lumbar Puncture Headache in the Outpatient Setting Rochester, MN. The purpose of this study is to better understand the ...

  9. Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation - Mayo Clinic

    The purpose of this study is to determine the incidence of rPSC in LT recipients treated with fenofibrate, compared with an untreated control cohort.

  10. Metoclopramide (nasal route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Agitation; black, tarry stools; bluish-colored lips, fingernails, or palms; blurred vision; chest pain or tightness; chills; clay-colored ...